Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Construction In Progress: ¥562 Mil (As of Mar. 2026)


SHSE:688336 Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd SHSE:688336
83 GF Score
Price ¥60.72
GF Value ¥66.76
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Sunshine Guojian Pharmaceutical (Shanghai) Co Construction In Progress?

Sunshine Guojian Pharmaceutical (Shanghai) Co SHSE:688336 +2.64% 83 Construction In Progress is ¥562 Mil as of Mar. 2026. GuruFocus rates SHSE:688336 with a GF Score™ of 83/100 and a GF Value™ of ¥66.76 (Fairly Valued). The stock has 3 warning signs investors should review.

Sunshine Guojian Pharmaceutical (Shanghai) Co's quarterly construction in progress increased from Sep. 2025 (¥533 Mil) to Dec. 2025 (¥544 Mil) and increased from Dec. 2025 (¥544 Mil) to Mar. 2026 (¥562 Mil).

Sunshine Guojian Pharmaceutical (Shanghai) Co's annual construction in progress increased from Dec. 2023 (¥688 Mil) to Dec. 2024 (¥750 Mil) but then declined from Dec. 2024 (¥750 Mil) to Dec. 2025 (¥544 Mil).

Sunshine Guojian Pharmaceutical (Shanghai) Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for Sunshine Guojian Pharmaceutical (Shanghai) Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunshine Guojian Pharmaceutical (Shanghai) Co Construction In Progress Chart

Sunshine Guojian Pharmaceutical (Shanghai) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 572.47 717.12 687.81 749.65 544.11

Sunshine Guojian Pharmaceutical (Shanghai) Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 764.14 771.63 533.41 544.11 562.08
SHSE:688336
83GF Score
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd SHSE:688336
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunshine Guojian Pharmaceutical (Shanghai) Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ¥562 Mil mean?
Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) has a Construction In Progress of ¥562 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co's Construction In Progress too high?
Sunshine Guojian Pharmaceutical (Shanghai) Co's current Construction In Progress is ¥562 Mil. Overall, Sunshine Guojian Pharmaceutical (Shanghai) Co has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sunshine Guojian Pharmaceutical (Shanghai) Co's Construction In Progress compare to VRTX and REGN?
Sunshine Guojian Pharmaceutical (Shanghai) Co's Construction In Progress of ¥562 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors. Sunshine Guojian Pharmaceutical (Shanghai) Co's current Construction In Progress is ¥562 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) is currently considered Fairly Valued. The stock's GF Value™ is ¥66.76, compared to a current price of ¥60.72 — trading 9% below its estimated fair value. The current Construction In Progress is ¥562 Mil. Sunshine Guojian Pharmaceutical (Shanghai) Co's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336), the current Construction In Progress is ¥562 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Overvalued in 2026?

Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co stock appears to be undervalued. The current stock price of ¥60.72 is trading 9% below its estimated GF Value™ of ¥66.76. GuruFocus considers Sunshine Guojian Pharmaceutical (Shanghai) Co to be Fairly Valued.

Key valuation signals for SHSE:688336:

  • Construction In Progress: ¥562 Mil
  • GF Value™: ¥66.76 vs. price of ¥60.72 (9% below fair value)
  • GF Score™: 83/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688336 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sunshine Guojian Pharmaceutical (Shanghai) Co Business Description

Address No.399 Libing Road, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd is a biopharmaceutical company providing safe and effective clinical solutions for the treatment of major diseases such as autoimmune diseases and tumors. The company engages in in research and development, manufacturing and commercialization of therapeutic antibody drugs in China. Its products portfolio includes YISAIPU and Xenopax. Its products in pipeline include 302H, 304R, 602, 601A, 609A and 301S.
83GF Score

Get the complete analysis for SHSE:688336

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥60.72
Price
¥66.76
GF Value